Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1538368881
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
800 NE 10th St
Oklahoma City, OK, 73104
Phone (405) 271-8001
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
237 services
Medicare patients, 2024
107
Average age 65
Drug cost, 2024
$2.9M
685 prescriptions
Company payments, 2025
$783
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James D Battiste was code 99214 (office e&m - established), 82 times for 59 patients. In total James D Battiste billed 237 services in 13 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 82 | 59 | $62.74 | $5,145 |
| 99215 Office E&M - Established | Facility | 80 | 51 | $100.75 | $8,060 |
| 99205 Office E&M - New | Facility | 21 | 21 | $116.52 | $2,447 |
| 99213 Office E&M - Established | Facility | 19 | 18 | $46.47 | $883 |
By year: 2022 $26K for 318 services; 2023 $21K for 280 services; 2024 $19K for 237 services.
Medicare prescription drug claims, 2024
In 2024, the drug James D Battiste prescribed most often to Medicare patients was Tibsovo (Ivosidenib), with 52 prescriptions and refills. In total James D Battiste wrote 685 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tibsovo Ivosidenib | 52 | 52 | Under 11 | $1.5M |
| Ondansetron Hcl Generic | 51 | 51 | 25 | $468 |
| Levetiracetam Generic | 50 | 91 | 19 | $836 |
| Dexamethasone Generic | 45 | 46 | 19 | $659 |
| Lacosamide Generic | 36 | 36 | 11 | $2,687 |
| Hydroxyzine Pamoate Generic | 28 | 28 | 12 | $292 |
| Clonazepam Generic | 27 | 27 | Under 11 | $365 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 32 | 20 | $86.44 |
| Pantoprazole Sodium Generic | 23 | 25 | Under 11 | $188 |
| Methylphenidate Hcl Generic | 21 | 21 | Under 11 | $416 |
| Prochlorperazine Maleate Generic | 15 | 15 | Under 11 | $218 |
| Koselugo Selumetinib Sulfate | 14 | 14 | Under 11 | $254K |
| Firdapse Amifampridine Phosphate | 14 | 14 | Under 11 | $282K |
| Gleostine Lomustine | 13 | 14 | Under 11 | $14K |
| Gabapentin Generic | 13 | 21 | Under 11 | $358 |
Brand drugs: - claims; generic drugs: 514 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James D Battiste $783 ($783 in general payments such as food, travel and fees) from 8 companies. The largest payer was Caris MPI, Inc. with $166.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.